Research on small RNA molecules could bring new therapies

The discovery of small RNA molecules and their relevance for gene regulation has dramatically changed our understanding of many essential cellular processes - and provides the opportunity to develop new ways for treating various diseases.

By selectively inhibiting gene expression and thereby ‘silencing’ genes involved in pathogenesis, the RNA molecules constitute a unique tool to treat cancer, neurological disorders or viral infections and other human diseases. At the XX International Congress of Genetics, held in Berlin (12-17 July) experts will present results from the latest research in RNA biology and discuss potential applications.
‘Today, small RNAs are increasingly developing into a therapeutic tool and there is reasonable hope that this will be successful in the near future,’ explained Professor Alfred Nordheim, Secretary General of the XX International Congress of Genetics.
Apart from RNA genetics, modern genetic research is already contributing much to combat diseases. In recent years, improved sequencing techniques made possible the rapid diagnosis of infectious bacteria or other pathogens. Bacterial cultures of patient specimens, which often take days to grow in the lab, thus become redundant, and effective therapies can be implemented sooner. ‘There is hardly a
disease without a genetic component’, the professor observed. ‘Not only pathogens, but also food, lifestyle or radiation can make us sick by influencing and changing our genetic information, or its expression. We are now beginning to understand the functioning of a cell on the molecular level.’

30.04.2008

More on the subject:

Related articles

Photo

News • Post-injury axon regrowth

Lab-grown model shows ‘irreversible’ spinal cord damage may be reversed

When the spinal cord is damaged, the resulting paralysis is usually considered permanent. Now, a new research approach using lab-grown organoid models suggests that it actually might be reversed.

Photo

News • Amyotrophic lateral sclerosis

ALS subtypes: why pathology spreads differently among patients

New research has found that a genetic factor best known for increasing the risk of Alzheimer's disease, may also influence how pathological changes spread in amyotrophic lateral sclerosis (ALS).

Photo

News • Neurology

When the ageing brain loses its molecular balance

Researchers at the Leibniz Institute on Aging have shown that oxidative stress impairs protein quality control in the brain – and that this process is reversible.

Subscribe to Newsletter